P442 Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients

2021 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []